Directory

Every key opinion leader in the directory, every fact cited to its public source.

Clear all

Showing 1–9 of 9 KOLs

Sort

Company: Iovance Biotherapeutics

Corey Cutler, MD

Dana-Farber Cancer Institute

Active 2026

Enriched profilefindmyKOL typeLeukemiaHematologyNortheast · MA

834
publications: 106
h-index: 13
trials

View profile →

Frederick Locke, MD

H. Lee Moffitt Cancer Center and Research Institute

Active 2026

Enriched profilefindmyKOL typeMyelomaHematology / OncologySoutheast · FL

863
publications: 62
h-index: 8
trials

View profile →

Richard Maziarz, MD

Oregon Health & Science University

Active 2026

Enriched profilefindmyKOL typeLeukemiaHematology / OncologyWest · OR

720
publications: 86
h-index: 9
trials

View profile →

James Gulley, MD

National Cancer Institute

Active 2026

Enriched profilefindmyKOL typeGenitourinaryHematology / OncologyNortheast · MD

985
publications: 89
h-index: 28
trials

View profile →

Evan Lipson, MD

Johns Hopkins University

Active 2026

Enriched profilefindmyKOL typeMelanomaMedical OncologyNortheast · MD

373
publications: 57
h-index: 6
trials

View profile →

Brendan Curti, MD

Providence Cancer Institute

Active 2025

Enriched profilefindmyKOL typeBreastMedical OncologyWest · OR

410
publications: 53
h-index: 17
trials

View profile →

Jared Weiss, MD

University of North Carolina at Chapel Hill

Active 2025

Basic profilefindmyKOL typeOncologyHematology / OncologySoutheast · NC

96
publications: 32
h-index: 16
trials

View profile →

Diwakar Davar, MBBS, MSc

UPMC Hillman Cancer Center

Active 2026

Enriched profilefindmyKOL typeGenitourinaryHematology / OncologyNortheast · PA

333
publications: 31
h-index: 16
trials

View profile →

Jared Weiss, MD

University of North Carolina at Chapel Hill

Active 2026

Enriched profileGastrointestinalHematology / OncologySoutheast · NC

—
publications: 32
h-index: 17
trials

View profile →